C
25.99
-0.21 (-0.80%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 混合的 | |
| 股票 | CeriBell, Inc. | - | - |
AIStockmoo 评分
2.0
| 分析师共识 | 5.0 |
| 内部交易活动 | NA |
| 价格波动 | 1.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 2.00 |
|
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 内部持股比例 | 26.96% |
| 机构持股比例 | 39.53% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 36.00 (TD Cowen, 38.52%) | 购买 |
| 中 | 32.50 (25.05%) | |
| 低 | 32.00 (JP Morgan, 23.12%) | 购买 |
| 32.00 (B of A Securities, 23.12%) | 购买 | |
| 平均值 | 33.25 (27.93%) | |
| 总计 | 4 购买 | |
| 平均价格@调整类型 | 28.50 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Canaccord Genuity | 09 Dec 2024 | 33.00 (26.97%) | 购买 | 30.04 |
| 13 Nov 2024 | 31.00 (19.28%) | 购买 | 27.88 | |
| TD Cowen | 09 Dec 2024 | 36.00 (38.51%) | 购买 | 30.04 |
| 05 Nov 2024 | 31.00 (19.28%) | 购买 | 26.96 | |
| B of A Securities | 05 Nov 2024 | 32.00 (23.12%) | 购买 | 26.96 |
| JP Morgan | 05 Nov 2024 | 32.00 (23.12%) | 购买 | 26.96 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| BLUMBERG SCOTT | - | - | 0 | 0 |
| 累积净数量 | 0 | |||
| 累积净值 ($) | 0 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | - | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| BLUMBERG SCOTT | 职员 | 23 Dec 2024 | 执行期权 | 1,000 | - | - |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合